|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Limb mass | 15.03.05.019 | 0.000880% | | Not Available |
| Loss of therapeutic response | 08.06.01.041 | 0.002240% | | Not Available |
| Malignant glioma | 17.20.02.003; 16.30.02.003 | 0.000400% | | Not Available |
| Marburg's variant multiple sclerosis | 17.16.01.010 | 0.000800% | | Not Available |
| Mesenteritis | 07.08.03.026 | 0.000400% | | Not Available |
| Multiple sclerosis pseudo relapse | 17.16.01.011 | 0.001360% | | Not Available |
| Myelin oligodendrocyte glycoprotein antibody-associated disease | 17.16.02.009; 10.04.10.020; 06.04.08.004 | 0.000400% | | Not Available |
| Myelomalacia | 17.10.01.029 | 0.000400% | | Not Available |
| Near death experience | 19.10.05.007; 17.02.04.023 | 0.000400% | | Not Available |
| Neurosarcoidosis | 17.06.01.005; 10.02.06.005 | 0.000400% | | Not Available |
| Noninfectious myelitis | 17.06.02.005; 10.02.01.095 | 0.000880% | | Not Available |
| Pancreatic failure | 07.18.02.011 | 0.001000% | | Not Available |
| Pancreatic haemorrhage | 24.07.02.067; 07.18.02.012 | 0.000400% | | |
| Perinatal depression | 19.15.01.011; 18.06.03.003 | 0.001360% | | Not Available |
| Periorbital swelling | 23.04.01.025; 10.01.05.025; 06.08.03.032 | 0.002040% | | Not Available |
| Pharyngeal swelling | 22.04.05.028 | 0.004281% | | Not Available |
| Primary biliary cholangitis | 10.04.09.004; 09.01.04.010 | 0.000600% | | Not Available |
| Pseudomyxoma peritonei | 16.32.03.045; 07.07.01.019 | 0.000400% | | Not Available |
| Relapsing multiple sclerosis | 17.16.01.012 | 0.002240% | | Not Available |
| Sensitive skin | 23.03.03.097 | 0.001360% | | Not Available |
| Spinal stenosis | 17.10.01.031; 15.10.04.014 | 0.002160% | | Not Available |
| Squamous cell carcinoma of the vulva | 21.08.03.009; 16.12.08.004 | 0.000400% | | Not Available |
| Subcapsular renal haematoma | 24.07.07.006; 20.01.02.021; 12.01.05.008 | 0.000400% | | Not Available |
| Subchorionic haematoma | 18.02.01.008; 24.07.03.037 | 0.000600% | | Not Available |
| Testicular germ cell tumour mixed | 21.13.02.011; 16.25.03.006 | 0.000400% | | Not Available |
| Therapeutic product effect decreased | 08.06.01.050 | - | - | Not Available |
| Therapy non-responder | 08.06.01.063 | - | - | Not Available |
| Treatment noncompliance | 12.09.02.006; 08.06.01.067 | - | - | Not Available |
| Triple negative breast cancer | 21.05.01.032; 16.10.01.020 | 0.000400% | | Not Available |
| Tumefactive multiple sclerosis | 17.16.01.013 | 0.001760% | | Not Available |
